Sarcoma: all 1,690 studies
Page 3 of 17. Open to participants first (391), then studies with results posted, then the rest; newest registration first within each.
- A Study of MGC026 in Participants With Advanced Solid TumorsRecruitingNCT06242470Phase 1
- NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)RecruitingNCT06239272Phase 1/2
- The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated VirusRecruitingNCT06236022Phase 4
- Safety and Feasibility of Intraoperative Visualization With Cytalux in ChildrenRecruitingNCT06235125Phase 1
- Superiority Trial Evaluating Digitalized Information Media for Patients With Advanced Sarcomas Receiving Systemic Treatment.RecruitingNCT06211257Not applicable
- Digital Peer Navigation for Adolescents and Young Adults With CancerRecruitingNCT06193369Not applicable
- A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue TumorsRecruitingNCT06171282Early Phase 1
- Study for the Clinical Roadmap and Prognosis of Pulmonary Artery Sarcoma.RecruitingNCT06165718
- Cabozantinib With Ifosfamide in Relapsed/Refractory SarcomasRecruitingNCT06156410Phase 1
- Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid TumorsRecruitingNCT06132503Phase 1
- Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With SarcomaRecruitingNCT06129903Not applicable
- Clinical Study of VG161 in the Treatment of Advanced Bone and Soft Tissue SarcomaRecruitingNCT06126510Phase 2
- Safety and Efficacy of NK510 to Treat Osteosarcoma and Soft Tissue SarcomaRecruitingNCT06117878Early Phase 1
- Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma (SeliSarc)RecruitingNCT06114004Phase 2
- Palbociclib and Pembrolizumab in SarcomaRecruitingNCT06113809Phase 1
- A Study Involving Collection of Samples and Data From Sarcoma Patients Receiving ImmunotherapyEnrolling by invitationNCT06113315
- A Study of Surufatinib in the Treatment of Advanced Soft Tissue SarcomaNot yet recruitingNCT06110650Not applicable
- Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)RecruitingNCT06103669Not applicable
- 5-Day Preoperative Radiation for Soft Tissue SarcomaRecruitingNCT06087861Phase 2
- A Phase I Trial of Memory T Cells Expressing an NKG2D Chimeric Antigen Receptor in Children, Adolescents and Young Adults With Advanced SarcomaRecruitingNCT06087341Phase 1
- GENomic PROfilation for Therapeutic Purposes in SARComas and Molecular Tumor Board (MTB): Retrospective/Prospective Study in Referral CentersRecruitingNCT06076070
- PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA)RecruitingNCT06074692Phase 2
- GRID Therapy for Extremity Soft Tissue SarcomaRecruitingNCT06073067Not applicable
- Geno-radiomics Based Model for Evaluation of Immunotherapy and Targeted Therapy for Advanced Soft Tissue SarcomaRecruitingNCT06062927
- A Study to Evaluate Pre-operative HYPOfractionated Radiation Therapy in Aged (≥ 70 Years Old) or "Fragile" (≥ 65 Years) Patients With Limb or Trunk Soft Tissue SARComa.RecruitingNCT06022159Phase 2
- A Study of CRD3874-SI in People With Solid TumorsRecruitingNCT06021626Phase 1
- Predicting Radiotherapy Response and Toxicities in Soft Tissue Sarcoma of the Extremities - Cohort BRecruitingNCT05978024
- Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer PatientsAvailableNCT05974410
- Clinical Application of 18F-PFPN PET Imaging in Diagnosis and Staging of Clear Cell Sarcoma of Soft TissueRecruitingNCT05963035Not applicable
- Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma PatientsRecruitingNCT05961761Phase 2
- A Study of ILB2109 and Toripalimab in Patients With Advanced Solid MalignanciesRecruitingNCT05955105Phase 1/2
- Clinical Trial of Infusion of Activated NK Cells for the Treatment of SarcomasRecruitingNCT05952310Not applicable
- Phase Ib/II Study of Fluzoparib in Combination With Dalpiciclib in Patients With Locally Advanced or Metastatic SarcomaRecruitingNCT05952128Phase 2
- IVIM & OLINK in SarcomaRecruitingNCT05950594Phase 2
- Study Comparing Negative Pressure Dressing vs Conventional in Patients With Resected STS After RadiotherapyRecruitingNCT05944913Not applicable
- HTL0039732 in Participants With Advanced Solid TumoursRecruitingNCT05944237Phase 1/2
- Efficacy and Safety of Cadonilimab Plus Anlotinib in Advanced STS That Failed the Previous First-line Standard TreatmentRecruitingNCT05926700Phase 2
- Pre-operative Hypofractionated Proton TherapyRecruitingNCT05917301Not applicable
- Synovial Sarcoma Registry / Biospecimen RepositoryRecruitingNCT05910307
- Brachytherapy (Iodine-125 Seeds) and Fluzoparib Combination Therapy for Advanced Unresectable Soft Tissue SarcomaRecruitingNCT05894018Phase 2
- Engineering Immune Organoids to Study Pediatric CancerRecruitingNCT05890781Not applicable
- Molecular Mechanism Study of Uterine SarcomaRecruitingNCT05881967
- A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue TumorsRecruitingNCT05851456Early Phase 1
- Neoadjuvant Chemotherapy Combined With Targeted Treatment in High-risk Retroperitoneal SarcomaEnrolling by invitationNCT05844813Phase 4
- The Combination of Radiotherapy，Surufatinib and Sintilimab in High-Risk Localized Soft Tissue SarcomaRecruitingNCT05839275Phase 1/2
- A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft TissueRecruitingNCT05837767Not applicable
- ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other SarcomasRecruitingNCT05830123Phase 2
- A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)RecruitingNCT05824975Phase 1/2
- Sarcoma Preoperative Radiation With Simultaneous INTegrated Boost (SPRINT)RecruitingNCT05761054Not applicable
- A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue SarcomaRecruitingNCT05755113Phase 2
- Disease Outcomes and Toxicities in Patients With Gastrointestinal and Sarcomatous MalignanciesRecruitingNCT05743426
- Gene Signatures Searching of Sensitivity/Resistance to Neoadjuvant Radiotherapy in Patients With Resectable STSRecruitingNCT05739084
- Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing SarcomaRecruitingNCT05734066Phase 1/2
- Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid TumorsRecruitingNCT05732831Phase 1/2
- Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic SarcomaRecruitingNCT05726383Phase 2
- Surufatinib and Envafolimab as Second or More-line Therapy in Advanced Soft Tissue Sarcoma PatientsNot yet recruitingNCT05722977Phase 2
- Piamprilizumab (AK105) Combined With Radiotherapy for Neoadjuvant Treatment of Soft Tissue SarcomaRecruitingNCT05718778Not applicable
- Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced SarcomaRecruitingNCT05711615Phase 1
- Multiparametric Quantitative MRI and Response to Neoadjuvant Radiotherapy for Soft-tissue SarcomaRecruitingNCT05684874Not applicable
- Pazopanib With or Without Pembrolizumab for Metastatic Soft Tissue SarcomaRecruitingNCT05679921Phase 2
- Phase II Trial of Lung ChemoemobolizationRecruitingNCT05672108Phase 2
- Cadonilimab in the Treatment of Advanced Soft Tissue SarcomaNot yet recruitingNCT05656144Phase 2
- Study of NY-ESO-1 TCR-T in Advanced Soft Tissue SarcomaRecruitingNCT05620693Not applicable
- Lenvatinib for Advanced Bone and Soft Tissue SarcomaRecruitingNCT05617859Phase 2
- Endoscopic Surgery in the Treatment of Soft Tissue Sarcoma in Nasal and Paranasal SinusRecruitingNCT05614375
- Catequentinib in Patients Who Have Completed an Advenchen Study (A Compassionate Use Trial)AvailableNCT05612191
- tTF-NGR Randomized Study - STSRecruitingNCT05597917Phase 3
- Biobank and Register of Patients With Agresive Tumors for Translational and Analytical ResearchRecruitingNCT05539677
- Individualized Prehabilitation for Enhancing Recovery and Surgical Outcomes in Patients Undergoing Radiotherapy and Surgery for Soft Tissue SarcomaRecruitingNCT05526417Not applicable
- Phase 1b/2 Study of Liposomal Annamycin (L-Annamycin) in Subjects With Previously Treated Soft-Tissue Sarcomas (STS) With Pulmonary MetastasesRecruitingNCT05518526Phase 1/2
- Registry For Children, Adolescents And Adults With Osteosarcoma And Biologically Related Bone SarcomasNot yet recruitingNCT05515068
- START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of CancerRecruitingNCT05492682Phase 1
- Study on Clinical Features, Treatment Mode and Survival of SarcomaRecruitingNCT05453409
- Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or LymphomasRecruitingNCT05415098Phase 1
- Registration Study SarcomaRecruitingNCT05373810
- cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual DiseaseRecruitingNCT05366881
- Global collaboRAtion on CIC-DUX4, BCOR-CCN3, High-grade Undifferentiated Round Cell Sarcoma (URCS) ProjectRecruitingNCT05357768
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionRecruitingNCT05334069
- Use of GnRHa During Chemotherapy for Fertility ProtectionRecruitingNCT05328258Phase 3
- Prognosis of Low-grade Endometrial Stromal SarcomaRecruitingNCT05310318
- Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With CancerRecruitingNCT05297734Not applicable
- Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic CancersRecruitingNCT05296564Phase 1/2
- A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)Enrolling by invitationNCT05266196Phase 1/2
- Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for SarcomasRecruitingNCT05253131Phase 2
- Preoperative Ultra-hypofractionated Radiotherapy Followed by Surgery for Retroperitoneal Sarcoma (FUSION-01)RecruitingNCT05224934Not applicable
- Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory SarcomasRecruitingNCT05210374Phase 1
- Albumin-bound Paclitaxel Plus Camrelizumab for Advanced Soft Tissue Sarcoma.RecruitingNCT05189483Phase 2
- Combination of Pembrolizumab and Cabozantinib in Patients With Advanced SarcomasRecruitingNCT05182164Phase 2
- Preoperative IMRT With Anlotinib and Penpulimab for Localized Sarcoma （SPARE-01）RecruitingNCT05167994Phase 2
- Multicohort Trial of Different Schemes of PM14 in Monotherapy and in Combination with Radiotherapy in Soft Tissue Sarcomas and Other Solid TumorRecruitingNCT05146440Phase 1/2
- A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid TumorsRecruitingNCT05135975Phase 2
- Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic SarcomasRecruitingNCT05131386Phase 2
- HIFU Ablation of Soft Tissue SarcomaRecruitingNCT05111964Not applicable
- HHV8 and Solid Organ TransplantationRecruitingNCT05081141
- Wide Excision of Soft Tissue Sarcomas in Combination With Interstitial Radiation TherapyRecruitingNCT05057195Not applicable
- 3D Printed Implants for the Defect Reconstruction in Patients With Chest Wall TumorsRecruitingNCT05057143Not applicable
- Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone TumorsRecruitingNCT05057130Phase 2/3
- Assessment of the Functional Outcome and Quality of Life in Sarcoma PatientsRecruitingNCT05051059Not applicable
- Atezolizumab Plus Tivozanib in Immunologically Cold Tumor TypesRecruitingNCT05000294Phase 1/2
- HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced SarcomaRecruitingNCT04995003Phase 1